Keywords: viral hepatitis; hepatitis C; infection; statistical data; Switzerland

Keywords: prevention; adolescent; alcoholic beverage; tobacco product; cannabis product; illicit drug; survey; school; causes of AODU; educational environment; setting; health information and education; program evaluation; tetrahydrocannabinol; Aodd; AODR mental disorder; emotional and psychiatric depression; AODR psychosis; schizophrenia; adolescence; psychological development; follow-up study; attitude toward AOD; AOD use; protective factors; risk factors; family dysfunction; diagnosis; AOD abuse; AOD consumption; external control; advertising; AOD use pattern; advertising ban; tobacco in any form; AOD price; nicotine replacement; taxes; community-based prevention; AODR mortality; lung cancer; heart disorder; cost-effectiveness; social and economic cost of AOD; developing country; international differences; risk-taking behavior; high-risk youth; secondary prevention; prevention program; meta-analysis; prevention research; hazardous AOD use; intergenerational relations; brief intervention; aggressive behavior; attention deficit disorder with hyperactivity; hyperactive behavior; childhood emotional disorder; problems at school; methylphenidate; Ritalin; parent; teacher; child; pathological gambling; gambling; epidemiology; public policy on AOD; coordination of activities; AOD effects and consequences; overview; heroin; public policy on illicit drugs; harm reduction; harm reduction policy; history of AOD use; history of AOD public policy; Europe; Switzerland; French-speaking Switzerland

Keywords: harm reduction

Keywords: research; health services, prevention, and treatment research; research in general; multiple sclerosis; tetrahydrocannabinol; cannabis product; MDMA; ecstasy; electroencephalography; emotion; serotonin; dopamine; norepinephrine; volunteer health care worker; methadone; genetic polymorphism; individual differences; buprenorphine; AOD dependence; opioids in any form; methadone maintenance; randomized controlled trial; pharmacodynamics; physiology; hypoventilation; urinalysis; hair analysis; sweat analysis; social cost of AOD; quality of life; cost-benefit analysis; search and seizure; adulteration; quantitative data analysis; opioid contaminant; law enforcement agency; AOD consumption; heroin; deoxyhemoglobin; spectroscopy; liposomes; pulmonary administration; heroin-assisted treatment; trial study; AOD use and driving; cognitive ability; epidemiological indicators; smoking; tobacco product; health and disease; general population survey; AOD demand; factor analysis; price elasticity of demand; knowledge, attitudes, and practices; taxes; cessation of AODU; population dynamics; occasional AOD use; behavioral change; stages of change; AODR mortality; prevalence; outpatient care; professional counseling; counseling service; program planning, implementation, and evaluation; organizational development; content analysis; psychoactive substances; antianxiety tranquilizers; narcotic analgesics; laxatives; cough syrup; appetite suppressants; gender; epidemiology; nightlife; urban area; AOD use pattern; designer drug; research chemical; illicit drug; sociology; cocaine; protective factors; estimation; mathematical model; incidence; harm reduction; drug user; drug evaluation; drug safety; dissemination of warnings; dissemination of AODE information; adolescent; underage smoking; AOD prevention; risk factors; lipids; heart disorder; case management; alcohol dependence; disease severity; validation study; AODR disability; primary health care; physician; identification and screening; alcohol use test; CAGE Questionnaire; AOD use, abuse, and dependence; comorbidity; treatment and maintenance; morbidity; economic cost of AODU; treatment cost; health care costs; human resources; labor costs; Switzerland; Europe; drug substitution therapy

Keywords: prevention